Large language models popularized by ChatGPT show up in nearly all of FDA Commissioner Robert Califf’s speeches lately, as he makes clear he wants to get ahead of regulating the disruptive technology.
An appropriations bill from a committee in the U.S. House of Representatives would direct the FDA to unify its food program under one person.
The move echoes the sentiment from a House committee, former FDA leaders, and experts in the field of food safety.
It seemed an excellent test case for a new system. After role-playing a U.S. Food and Drug Administration Tobacco Products Scientific Advisory Committee (TPSAC) member, listening to Altria’s presenters rehearse their pitch, that was my impression.
Commissioner Robert Califf continues to raise attention about what he terms the “revolving door for lawyers,” between the FDA and industry.
Agency staff leaving for jobs in the private sector is nothing new, but Califf mentioned during a speech at the Food and Drug Law Institute’s Annual Conference that the attention seems directed at departing scientists, rather than attorneys.
Commissioner Robert Califf continues to raise attention about what he terms the “revolving door for lawyers,” between the FDA and industry.
Agency staff leaving for jobs in the private sector is nothing new, but Califf mentioned during a speech at the Food and Drug Law Institute’s Annual Conference that the attention seems directed at departing scientists, rather than attorneys.
U.S. Food and Drug Administration Commissioner Robert Califf has lamented the FDA’s ongoing tobacco industry litigation following the agency’s attempt to regulate e-cigarettes, according to Politico. The FDA is facing over 40 lawsuits from companies whose premarket tobacco product applications have been denied.
US Food and Drug Administration Commissioner Robert Califf’s evidence generation enhancement plans will include the National Institutes of Health, assuming that agency’s new leader takes office.
